ALUR Allurion Technologies Inc.
USHealthcareAs of 2026-07-02 09:30
Why ALUR matters now
Allurion Technologies Inc. (ALUR) is a US stock in Healthcare. The latest InvestLog snapshot shows $5.50 with +14.58% on the session and $5.5M in market capitalization; recent performance reads 1-month -45.20% and YTD -59.46%.
The latest financial table shown here is Q1 2026, with revenue of $2.9M, net income of $-6.1M, and EPS of $-0.46. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -303.3%.
The latest indexable market news headline is "Allurion Advances Plan to Re-List" from Business Wire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $3.00; recent insider activity includes Buch Ojas filing . These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.09
P/S
0.59
EV/EBITDA
-0.82
DCF Value
$-518.95
FCF Yield
-303.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
52.7%
Operating Margin
-211.2%
Net Margin
-264.7%
ROE
44.2%
ROA
-238.3%
ROIC
-503.2%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $2.9M | $-6.1M | $-0.46 |
| Q4 2025 | $3.6M | $-6.0M | $-0.69 |
| FY 2025 | $15.2M | $-28.8M | $-3.81 |
| Q3 2025 | $2.7M | $-11.9M | $-1.53 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$3.00
Target (Median)
$3.00
Target Range
$3.00 - $3.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
-0.17
Allurion Technologies Inc. is dedicated to combating obesity by offering a comprehensive weight management ecosystem designed for individuals with excess weight. At the core of its solution is the Allurion Program, featuring the innovative Allurion Balloon – a novel, non-surgical, swallowable intragastric device engineered to promote significant weight loss. This program is further enhanced by the Allurion Virtual Care Suite, which provides sophisticated AI-powered remote patient monitoring, a specialized behavior modification curriculum, encrypted messaging capabilities, and virtual telehealth consultations. The firm's main operational base is located in Natick, Massachusetts.